185 related articles for article (PubMed ID: 19458334)
1. Using the NAFX to measure the effectiveness over time of gene therapy in canine LCA.
Jacobs JB; Dell'Osso LF; Wang ZI; Acland GM; Bennett J
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4685-92. PubMed ID: 19458334
[TBL] [Abstract][Full Text] [Related]
2. Eye movement recordings as an effectiveness indicator of gene therapy in RPE65-deficient canines: implications for the ocular motor system.
Jacobs JB; Dell'Osso LF; Hertle RW; Acland GM; Bennett J
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2865-75. PubMed ID: 16799026
[TBL] [Abstract][Full Text] [Related]
3. Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog.
Narfström K; Katz ML; Bragadottir R; Seeliger M; Boulanger A; Redmond TM; Caro L; Lai CM; Rakoczy PE
Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1663-72. PubMed ID: 12657607
[TBL] [Abstract][Full Text] [Related]
4. Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transfer.
Bennicelli J; Wright JF; Komaromy A; Jacobs JB; Hauck B; Zelenaia O; Mingozzi F; Hui D; Chung D; Rex TS; Wei Z; Qu G; Zhou S; Zeiss C; Arruda VR; Acland GM; Dell'Osso LF; High KA; Maguire AM; Bennett J
Mol Ther; 2008 Mar; 16(3):458-65. PubMed ID: 18209734
[TBL] [Abstract][Full Text] [Related]
5. Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness.
Acland GM; Aguirre GD; Bennett J; Aleman TS; Cideciyan AV; Bennicelli J; Dejneka NS; Pearce-Kelling SE; Maguire AM; Palczewski K; Hauswirth WW; Jacobson SG
Mol Ther; 2005 Dec; 12(6):1072-82. PubMed ID: 16226919
[TBL] [Abstract][Full Text] [Related]
6. Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis.
Jacobson SG; Boye SL; Aleman TS; Conlon TJ; Zeiss CJ; Roman AJ; Cideciyan AV; Schwartz SB; Komaromy AM; Doobrajh M; Cheung AY; Sumaroka A; Pearce-Kelling SE; Aguirre GD; Kaushal S; Maguire AM; Flotte TR; Hauswirth WW
Hum Gene Ther; 2006 Aug; 17(8):845-58. PubMed ID: 16942444
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy in the second eye of RPE65-deficient dogs improves retinal function.
Annear MJ; Bartoe JT; Barker SE; Smith AJ; Curran PG; Bainbridge JW; Ali RR; Petersen-Jones SM
Gene Ther; 2011 Jan; 18(1):53-61. PubMed ID: 20703309
[TBL] [Abstract][Full Text] [Related]
8. An expanded nystagmus acuity function: intra- and intersubject prediction of best-corrected visual acuity.
Dell'Osso LF; Jacobs JB
Doc Ophthalmol; 2002 May; 104(3):249-76. PubMed ID: 12076015
[TBL] [Abstract][Full Text] [Related]
9. Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.
Le Meur G; Stieger K; Smith AJ; Weber M; Deschamps JY; Nivard D; Mendes-Madeira A; Provost N; Péréon Y; Cherel Y; Ali RR; Hamel C; Moullier P; Rolling F
Gene Ther; 2007 Feb; 14(4):292-303. PubMed ID: 17024105
[TBL] [Abstract][Full Text] [Related]
10. Gene therapeutic prospects in early onset of severe retinal dystrophy: restoration of vision in RPE65 Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.
Rolling F; Le Meur G; Stieger K; Smith AJ; Weber M; Deschamps JY; Nivard D; Mendes-Madeira A; Provost N; Péréon Y; Cherel Y; Ali RR; Hamel C; Moullier P; Rolling F
Bull Mem Acad R Med Belg; 2006; 161(10-12):497-508; discussion 508-9. PubMed ID: 17503728
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye.
Li W; Kong F; Li X; Dai X; Liu X; Zheng Q; Wu R; Zhou X; Lü F; Chang B; Li Q; Hauswirth WW; Qu J; Pang JJ
Mol Vis; 2009; 15():267-75. PubMed ID: 19190735
[TBL] [Abstract][Full Text] [Related]
12. Combined gaze-angle and vergence variation in infantile nystagmus: two therapies that improve the high-visual-acuity field and methods to measure it.
Serra A; Dell'Osso LF; Jacobs JB; Burnstine RA
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2451-60. PubMed ID: 16723456
[TBL] [Abstract][Full Text] [Related]
13. Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial.
Hauswirth WW; Aleman TS; Kaushal S; Cideciyan AV; Schwartz SB; Wang L; Conlon TJ; Boye SL; Flotte TR; Byrne BJ; Jacobson SG
Hum Gene Ther; 2008 Oct; 19(10):979-90. PubMed ID: 18774912
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial.
Maguire AM; High KA; Auricchio A; Wright JF; Pierce EA; Testa F; Mingozzi F; Bennicelli JL; Ying GS; Rossi S; Fulton A; Marshall KA; Banfi S; Chung DC; Morgan JI; Hauck B; Zelenaia O; Zhu X; Raffini L; Coppieters F; De Baere E; Shindler KS; Volpe NJ; Surace EM; Acerra C; Lyubarsky A; Redmond TM; Stone E; Sun J; McDonnell JW; Leroy BP; Simonelli F; Bennett J
Lancet; 2009 Nov; 374(9701):1597-605. PubMed ID: 19854499
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy restores vision in a canine model of childhood blindness.
Acland GM; Aguirre GD; Ray J; Zhang Q; Aleman TS; Cideciyan AV; Pearce-Kelling SE; Anand V; Zeng Y; Maguire AM; Jacobson SG; Hauswirth WW; Bennett J
Nat Genet; 2001 May; 28(1):92-5. PubMed ID: 11326284
[TBL] [Abstract][Full Text] [Related]
16. The diagnosis and treatment of infantile nystagmus syndrome (INS).
Khanna S; Dell'Osso LF
ScientificWorldJournal; 2006 Oct; 6():1385-97. PubMed ID: 17086344
[TBL] [Abstract][Full Text] [Related]
17. Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation.
Aguirre GK; Komáromy AM; Cideciyan AV; Brainard DH; Aleman TS; Roman AJ; Avants BB; Gee JC; Korczykowski M; Hauswirth WW; Acland GM; Aguirre GD; Jacobson SG
PLoS Med; 2007 Jun; 4(6):e230. PubMed ID: 17594175
[TBL] [Abstract][Full Text] [Related]
18. Electroretinographic analyses of Rpe65-mutant rd12 mice: developing an in vivo bioassay for human gene therapy trials of Leber congenital amaurosis.
Roman AJ; Boye SL; Aleman TS; Pang JJ; McDowell JH; Boye SE; Cideciyan AV; Jacobson SG; Hauswirth WW
Mol Vis; 2007 Sep; 13():1701-10. PubMed ID: 17960108
[TBL] [Abstract][Full Text] [Related]
19. Effects of tenotomy on patients with infantile nystagmus syndrome: foveation improvement over a broadened visual field.
Wang Z; Dell'Osso LF; Jacobs JB; Burnstine RA; Tomsak RL
J AAPOS; 2006 Dec; 10(6):552-60. PubMed ID: 17189150
[TBL] [Abstract][Full Text] [Related]
20. RPE65: role in the visual cycle, human retinal disease, and gene therapy.
Cai X; Conley SM; Naash MI
Ophthalmic Genet; 2009 Jun; 30(2):57-62. PubMed ID: 19373675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
